EUVIMEDEUVIMED entdecken
Crossref

Triple Therapy with Empagliflozin, Linagliptin and Gliclazide in a Patient who Refuses Insulin: New Solutions to an Old Problem

Ricardo ET Navarrete

Diabetes & Obesity International Journal · 2016

DOI: 10.23880/doij-16000117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Obesity International Journal, 2016. Verfasst von Ricardo ET Navarrete. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Navarrete, R. E. (2016). Triple Therapy with Empagliflozin, Linagliptin and Gliclazide in a Patient who Refuses Insulin: New Solutions to an Old Problem. Diabetes & Obesity International Journal. https://doi.org/10.23880/doij-16000117

Vancouver

Navarrete RE. Triple Therapy with Empagliflozin, Linagliptin and Gliclazide in a Patient who Refuses Insulin: New Solutions to an Old Problem. Diabetes & Obesity International Journal. 2016. doi:10.23880/doij-16000117

BibTeX
@article{Navarrete2016,
  author = {Navarrete, Ricardo ET},
  title = {Triple Therapy with Empagliflozin, Linagliptin and Gliclazide in a Patient who Refuses Insulin: New Solutions to an Old Problem},
  journal = {Diabetes & Obesity International Journal},
  year = {2016},
  doi = {10.23880/doij-16000117}
}
Kostenlos starten →